The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global dermatology diagnostic devices market reached a value of US$13.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$23.6 Billion by 2027, exhibiting at a CAGR of 10.5% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Dermatology is the field of medicine which involves the study, diagnosis and treatment of skin diseases. Generally, the diagnosis is performed through a visual examination, followed by microscopic observation of the skin which helps in identifying the disease and specifying a treatment plan. In order to perform these procedures, dermatologists use a series of diagnostic devices such as imaging devices, microscopes and dermatoscopes. The demand for these devices is escalating on a global level on account of the rising cases of dermatological conditions and increasing concerns regarding skin health.
Global Dermatology Diagnostic Devices Market Drivers:
Various pollutants including polycyclic aromatic hydrocarbons, oxides and ultraviolet radiation cause damage to the skin by inducing oxidative stress. A rise in the prevalence of skin conditions, particularly hair fall, acne, eczema and psoriasis, owing to rapidly increasing levels of air pollution, has led to increased demand for dermatology diagnostic devices across the globe. Additionally, dermatology procedures have gained prominence in the cosmetics industry for several diagnostic services for individuals suffering from chronic skin conditions such as skin pigmentations, allergic reactions, benign skin growth, and fungal or bacterial infections. Moreover, several vendors in the global dermatology diagnostic devices market are focusing on expanding their product portfolios by offering devices for performing imaging techniques such as dermatoscopy and optical coherence tomography. They are also introducing devices that are smaller and easier to use.
IMARC Group provides an analysis of the key trends in each sub-segment of the global dermatology diagnostic devices market, along with forecasts at the global and regional level from 2022-2027. Our report has categorized the market based on product type and end-use.
Breakup by Product Type:
Imaging devices currently account for the highest share.
Breakup by End-Use:
The global dermatology diagnostic devices market consists of numerous small and large manufacturers. Some of the leading players operating in the market are Abbott Diagnostics, Strata Skin Sciences, Michelson Diagnostics, Heine Optotechnik, Roche Diagnostics, Welch Allyn, Carl Zeiss Meditec, Nikon Corporation, Leica Microsystems GmbH, MELA Sciences, Inc., GE Healthcare Ltd., Bruker Corporation, Philips Healthcare, Siemens Healthcare Diagnostics Inc., Toshiba Medical Systems Corporation, Photomedex, Inc.
|Base Year of the Analysis||2021|
|Segment Coverage||Product Type, End-Use, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Companies Covered||Abbott Diagnostics, Strata Skin Sciences, Michelson Diagnostics, Heine Optotechnik, Roche Diagnostics, Welch Allyn, Carl Zeiss Meditec, Nikon Corporation, Leica Microsystems GmbH, MELA Sciences, Inc., GE Healthcare Ltd., Bruker Corporation, Philips Healthcare, Siemens Healthcare Diagnostics Inc., Toshiba Medical Systems Corporation and Photomedex, Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at